Effects of an EP2 and EP3 Receptor Dual Agonist, ONO‐8055, on a Radical Hysterectomy‐Induced Underactive Bladder Model in Monkeys
- 25 April 2017
- journal article
- research article
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 10 (2) , 204-211
Abstract
Objectives: The objective was to develop an underactive bladder (UAB) model in primates and to evaluate the potential of prostanoid EP2 and EP3 receptor dual agonist ONO‐8055 to become a therapeutic agent for UAB.Methods: A surgical procedure resembling radical hysterectomy was performed on female cynomolgus monkeys. Subsequently, in vitro muscle strip studies were performed using bladder muscle strips from normal monkeys and monkeys that underwent surgery. In addition, uroflowmetric data were obtained at specified days after the surgery. To evaluate the effects of ONO‐8055 and distigmine (DIS) on voiding function in the UAB monkey model, uroflowmetry was performed approximately 1 week after the surgery, before and after the cumulative intravenous administration of the compounds at 2 h intervals.Results: In the bladder muscle strip studies, the responses to potassium chloride at 2 months, and carbachol and electrical field stimulation from 2 weeks decreased significantly. Voided volume (VV), maximum flow rate (Qmax), and average flow rate (Qave) decreased after surgery, while voiding time (VT) increased. In this model, ONO‐8055 and DIS significantly increased VV and Qmax. DIS prolonged VT, while ONO‐8055 had no effect. The results also showed that ONO‐8055 increased Qave.Conclusions: We developed a neurogenic UAB model in primates. As ONO‐8055 improved voiding function in this model to at least the same degree as DIS, this EP2 and EP3 receptor dual agonist has the potential to be a candidate for neurogenic UAB pharmacotherapy.Keywords
This publication has 18 references indexed in Scilit:
- Detrusor underactivity: A plea for new approaches to a common bladder dysfunctionNeurourology and Urodynamics, 2011
- Detrusor Underactivity/Underactive Bladder: New Research Initiatives NeededJournal of Urology, 2010
- Diabetic Bladder Dysfunction: Current Translational KnowledgeJournal of Urology, 2009
- Case for Pharmacotherapy Development for Underactive BladderUrology, 2008
- Change in acetylcholine release from rat bladder with partial outlet obstructionBJU International, 2007
- Is the use of parasympathomimetics for treating an underactive urinary bladder evidence‐based?BJU International, 2007
- Differential effects of TAK-802, a selective acetylcholinesterase inhibitor, and carbamate acetylcholinesterase inhibitors on contraction of the detrusor smooth muscle of the guinea pigLife Sciences, 2005
- Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigsEuropean Journal of Pharmacology, 2004
- Urinary Tract Dysfunction after Radical Hysterectomy for Cervical CancerGynecologic Oncology, 2002
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002